A serial entrepreneur educated in mathematics, artificial intelligence, biotechnology, entrepreneurship, and the arts, David has built a toolset perfectly fit for breakthrough pharmaceutical endeavors. He is obsessed with company culture and breaking down interdisciplinary silos to create a gestalt of expertise. Masters in Biotechnology, Harvard. Graduate Certificate Artificial Intelligence, Stanford. Entrepreneur Development Program, MIT.

Transformative executive w 30 years of drug development experience in leading pharmaceutical companies. Former Head of Digital Sciences at Allergan developing and implementing an AI / ML strategy for R&D. Recognized by CenterWatch as one of 20 innovators changing the face of the clinical trials industry. Served as the past Corporate Secretary of Transcelerate Biopharma, the largest R&D focused collaboration of the global pharmaceutical industry.

With a Ph.D. and postdoctoral training from Imperial College London in Epigenetics, Ziwei has extensive experience in translational research and drug discovery & development, particularly in antibody discovery and oncology cell therapy. Prior to Ordaos, Ziwei successfully led multiple programs from inception to efficacious in vivo studies at GlaxoSmithKline and the non-profit biotech New York Tri-Institutional Therapeutics Discovery Institute.